Home/Filings/4/0001209191-23-021209
4//SEC Filing

Desai Veeral 4

Accession 0001209191-23-021209

CIK 0001831097other

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 4:06 PM ET

Size

15.2 KB

Accession

0001209191-23-021209

Insider Transaction Report

Form 4
Period: 2023-03-23
Desai Veeral
Chief Strategy & Dev. Officer
Transactions
  • Sale

    Common Stock

    2023-03-23$28.71/sh22,710$651,911276,729 total
  • Exercise/Conversion

    Common Stock

    2023-03-24$3.00/sh+97,290$291,870374,019 total
  • Exercise/Conversion

    Common Stock

    2023-03-23$3.00/sh+22,710$68,130299,439 total
  • Exercise/Conversion

    Options (Rights to Buy)

    2023-03-2497,2901,520,000 total
    Exercise: $3.00Exp: 2027-04-27Common Stock (97,290 underlying)
  • Exercise/Conversion

    Options (Rights to Buy)

    2023-03-2322,7101,617,290 total
    Exercise: $3.00Exp: 2027-04-27Common Stock (22,710 underlying)
  • Sale

    Common Stock

    2023-03-24$28.70/sh97,290$2,792,379276,729 total
Footnotes (5)
  • [F1]Includes restricted stock units.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.50 to $28.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.50 to $28.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F5]These options were granted on April 27, 2017 and vested on September 14, 2021.

Issuer

agilon health, inc.

CIK 0001831097

Entity typeother

Related Parties

1
  • filerCIK 0001855973

Filing Metadata

Form type
4
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 4:06 PM ET
Size
15.2 KB